KOR
ENG
About us
Our Company
Founder’s Message
History
Members
Our Science
Platform
Pipelines
Disease Areas
Publications
Media
Company News
Contact us
Contact Us
KOR
ENG
About us
History
Our Company
Founder’s Message
History
Members
History
2018. 08
AIMEDBIO Inc. was founded
2019. 01
In-licensed the patents and resources
from Samsung Medical Center
2019. 08
AVATAMED PTE Ltd., a spin-off company
from A-star founded in Singapore
Visit AVATAMED
2019. 12
AIMEDBIO R&D Center OPEN
2020. 04
Genotwin, a spin-off company from
Columbia University
founded in New York
Visit Genotwin
2020. 06
AIMEDBIO initiates a joint lab with CBMED
to collaborate on precision medicine drug
screening project
Visit CBmed
2020.09
Licensed-in a brain-specific payload from
Samsung Medical Center & Sejong University
2021.05.
Strategic Investment from Yuhan Corporation
2021.11.
AMB302, a novel ADC potentially active in
brain cancer therapy, to receive grant from
Korea Drug Development Fund (KDDF)
2022.04.
Co-development agreement signed with
GeneQuantum Healthcare Co., Ltd., for AMB302,
a First-in-Class therapeutic ADC
2022.11.
Antibody therapeutics for solid cancer,
AMB018, selected as a Korea Drug
Development Fund (KDDF) Project
Members >>